Indian Pharmaceuticals & Biotech Mid-Large Cap Stocks

Aether Industries

Market Cap: ₹97.4b

Produces and sells advanced intermediates and specialty chemicals in India and internationally.

Cohance Lifesciences

Market Cap: ₹332.6b

Engages in the contract research, development, and manufacturing of new chemical entity (NCE) based intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs in India, the United States, Europe, and internationally.

Anthem Biosciences

Market Cap: ₹438.6b

Operates as technology-focused contract research, development, and manufacturing organization.

Mankind Pharma

Market Cap: ₹1.0t

Develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally.

OneSource Specialty Pharma

Market Cap: ₹205.0b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally.

Neuland Laboratories

Market Cap: ₹179.0b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

Wockhardt

Market Cap: ₹217.2b

Operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally.

Piramal Pharma

Market Cap: ₹249.3b

Operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally.

Acutaas Chemicals

Market Cap: ₹111.2b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.